Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Huse

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Advanced Biosystems|August 4, 2020
Modulating T Cell Activation Using Depth Sensing Topographic CuesParthiv Kant Chaudhuri, Mitchell S Wang, Charles T Black, et al.
Cancer Immunology Research|December 28, 2014
Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibodyHong Xu, Ming Cheng, Hongfen Guo, et al.
Nature Immunology|January 31, 2006
T cells use two directionally distinct pathways for cytokine secretionMorgan Huse, Björn F Lillemeier, Michael S Kuhns, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
T cell activation and immune synapse organization respond to the microscale mechanics of structured surfacesWeiyang Jin, Fella Tamzalit, Parthiv Kant Chaudhuri, et al.
Nature|February 23, 2005
Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivityMichelle Krogsgaard, Qi-Jing Li, Cenk Sumen, et al.
Annual Review of Immunology|February 13, 2007
T cells as a self-referential, sensory organMark M Davis, Michelle Krogsgaard, Morgan Huse, et al.
Organic Letters|February 14, 2002
Efficient semisynthesis of a tetraphosphorylated analogue of the Type I TGFbeta receptorRobert R Flavell, Morgan Huse, Mike Goger, et al.
Oncoimmunology|July 30, 2016
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumorsMing Cheng, Brian H Santich, Hong Xu, et al.
Science Translational Medicine|March 13, 2020
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodiesBrian H Santich, Jeong A Park, Hoa Tran, et al.
The Journal of Experimental Medicine|March 16, 2017
Correction: Annular PIP<sub>3</sub> accumulation controls actin architecture and modulates cytotoxicity at the immunological synapseAudrey Le Floc'h, Yoshihiko Tanaka, Niels S Bantilan, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Advanced Biosystems|August 4, 2020
Modulating T Cell Activation Using Depth Sensing Topographic CuesParthiv Kant Chaudhuri, Mitchell S Wang, Charles T Black, et al.
Cancer Immunology Research|December 28, 2014
Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibodyHong Xu, Ming Cheng, Hongfen Guo, et al.
Nature Immunology|January 31, 2006
T cells use two directionally distinct pathways for cytokine secretionMorgan Huse, Björn F Lillemeier, Michael S Kuhns, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
T cell activation and immune synapse organization respond to the microscale mechanics of structured surfacesWeiyang Jin, Fella Tamzalit, Parthiv Kant Chaudhuri, et al.
Nature|February 23, 2005
Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivityMichelle Krogsgaard, Qi-Jing Li, Cenk Sumen, et al.
Annual Review of Immunology|February 13, 2007
T cells as a self-referential, sensory organMark M Davis, Michelle Krogsgaard, Morgan Huse, et al.
Organic Letters|February 14, 2002
Efficient semisynthesis of a tetraphosphorylated analogue of the Type I TGFbeta receptorRobert R Flavell, Morgan Huse, Mike Goger, et al.
Oncoimmunology|July 30, 2016
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumorsMing Cheng, Brian H Santich, Hong Xu, et al.
Science Translational Medicine|March 13, 2020
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodiesBrian H Santich, Jeong A Park, Hoa Tran, et al.
The Journal of Experimental Medicine|March 16, 2017
Correction: Annular PIP<sub>3</sub> accumulation controls actin architecture and modulates cytotoxicity at the immunological synapseAudrey Le Floc'h, Yoshihiko Tanaka, Niels S Bantilan, et al.
Pageof 8